Metformin sensitizes clonally evolved imatinib–geldanamycin-resistant CML models through AMPK–HSF1 and AMPK–RUNX1 signaling
Cell Death
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Metformin sensitizes clonally evolved imatinib–geldanamycin-resistant CML models through AMPK–HSF1 and AMPK–RUNX1 signaling. // Cell Death. – URL: https://www.sciencedirect.com/science/article/pii/S3051115126000229?dgcid=rss_sd_all
Metformin sensitizes clonally evolved imatinib–geldanamycin-resistant CML models through AMPK–HSF1 and AMPK–RUNX1 signaling. Cell Death. https://www.sciencedirect.com/science/article/pii/S3051115126000229?dgcid=rss_sd_all
“Metformin sensitizes clonally evolved imatinib–geldanamycin-resistant CML models through AMPK–HSF1 and AMPK–RUNX1 signaling.” Cell Death.
@article{article2056,
title = {Metformin sensitizes clonally evolved imatinib–geldanamycin-resistant CML models through AMPK–HSF1 and AMPK–RUNX1 signaling},
journal = {Cell Death},
url = {https://www.sciencedirect.com/science/article/pii/S3051115126000229?dgcid=rss_sd_all}
}